Keywords: cell, genesys, gvax, trial, gets, idmc, go

Cell Genesys' GVAX trial gets IDMC go ahead

Article | 21 January 2008

USA-based biotechnology firm Cell Genesys says that, following the successful completion of an independent data monitoring board review, it is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Aventis

Aventis Pharma

Sanofi-Aventis

Go to company listing

Related Drugs

docetaxel

Taxotere

Deltasone

Prednisone

Go to drug listing